High-Impact Growth Dimagi

In Part 3 in our series on AI, Brian DeRenzi, head of Dimagi's research and data team, joins Jonathan Jackson and Amie Vaccaro to discuss how advances in AI can affect global health and development. They discuss AI's rapid evolution, practical applications, and the importance of thoughtful implementation to avoid a future where only the privileged benefit. The discussion covers Dimagi's focus on equitable AI through direct-to-client work, how AI can support health workers, and Dimagi’s new bot building and testing platform, Open Chat Studio. 



Discussion points:


AI Evolution: Exploring the rapid advancements in AI models and technologies


Dimagi's AI Projects: Insights into Dimagi's current AI initiatives and their goals


Generative AI in Healthcare: Practical applications and benefits for healthcare workers and clients


Equitable AI Deployment: Strategies to ensure AI technology is accessible to all


Open Chat Studio: Introduction to Dimagi's platform for developing and testing chatbots 


Language Accessibility: Challenges and progress in LLM’s support for low-resource language

Today we are sharing an episode from a podcast we think you'll enjoy. System Catalysts is about the incredible people who are fixing the broken systems that run the world.

---

Are you an organ donor? If yes, good for you! But you should know that your organs might not reach the person who needs them. That’s because the organ donation system is a mess, leading to over a dozen preventable deaths daily. Thankfully, our guests today – Greg Segal of Organize and Jennifer Erickson of Federation of American Scientists –  tell us about how they discovered the hidden problem in organ donation and how they’re going to fix it. If you want to learn more about Organize, visit organize.org.

Find more episodes at System Catalysts: https://www.systemcatalysts.com/episodes

System Catalysts is produced by Hueman Group Media.

---

Sign up to our newsletter⁠, and stay informed of Dimagi’s work

We are on social media - follow us for the latest from Dimagi: ⁠LinkedIn⁠, ⁠Twitter⁠, ⁠Facebook⁠⁠⁠, ⁠Youtube⁠⁠⁠⁠

If you enjoy this show, please leave us a 5-Star Review and share your favorite episodes with friends. 

Hosts: ⁠Jonathan Jackson⁠ and ⁠Amie Vaccaro

One in 800 babies are born with clubfoot, a treatable birth impairment that left untreated prevents a child from walking, and becomes the root cause for illiteracy, abuse, malnutrition, and poverty in many parts of the world. Clubfoot is routinely treated at birth in high income countries, but historically children born in low and middle income countries have not had access to quality treatment. Today, co-hosts Jonathan Jackson and Amie Vaccaro sit down with Chesca Colloredo-Mansfeld, co-founder of MiracleFeet to hear about how she and her team have dedicated themselves to making a simple, cost-effective treatment for clubfoot available to every baby born with the condition. They are on track to serve 100,000 children later this year with a goal to treat 70% of clubfoot cases in the countries they operate in. We discuss:


Chesca’s journey from the moment she realized she wanted to get out of the corporate world and discovered a fixable problem she could focus on, including her recent decision to step down as CEO to ensure long-term sustainability of the organization


How Chesca’s business background helped her take a different approach to building the organization and investing in technology to support its mission


The art of storytelling for a little known cause focused on dignity and possibility


How to fundraise from cost-effectiveness focused investors  


How the thoughtful implementation of a mobile data collection system (CommCare) allowed MiracleFeet’s providers to measure quality, deliver better services, and gather data to support continual fundraising


How to ensure quality while scaling an intervention


Pivotal moments in Chesca’s journey including breaking down in tears on a redeye to secure a $1 million grant from Google


Listening to your intuition and backing it up with rigorous data and analysis



Chapters:

01:26 Welcoming Chesca: The Journey Begins

01:57 Chesca's Backstory: From Global Childhood to Business World

03:55 Discovering a Treatment for Clubfoot: A Life-Changing Moment

05:16 The Birth of MiracleFeet: From Vision to Reality

05:34 Taking the Leap: Transitioning from Corporate to Social Impact

08:59 Building MiracleFeet: Challenges, Fundraising, and Growth

21:08 Reflections on Storytelling, Fundraising, and Instinct

27:19 Expanding Reach and Impact: The Future of MiracleFeet

39:11 Harnessing Technology for Global Health Impact

40:22 Innovative Solutions to Healthcare Challenges

42:57 Empowering Local Teams with Data

46:27 Navigating Founder Transition and Organizational Growth

56:53 Mentoring the Next Generation of Social Entrepreneurs

01:12:37 Reflections on Business Acumen in Nonprofit Success



MiracleFeet: https://www.miraclefeet.org/

MiracleFeet's use of CommCare: https://www.miraclefeet.org/stories/the-tool-that-saved-us-in-2020

Impact Delivery: https://sites.dimagi.com/impact-delivery

Sign up to our newsletter⁠, and stay informed of Dimagi’s work

We are on social media - follow us for the latest from Dimagi: ⁠LinkedIn⁠, ⁠Twitter⁠, ⁠Facebook⁠⁠⁠, ⁠Youtube⁠⁠⁠⁠

If you enjoy this show, please leave us a 5-Star Review and share your favorite episodes with friends. Hosts: ⁠Jonathan Jackson⁠ and ⁠Amie Vaccaro

Co-hosts, Jonathan Jackson and Amie Vaccaro are joined by Jeroo Billimoria, a remarkable serial social entrepreneur. Starting at age 12, Jeroo has founded several impactful organizations, including Child and Youth Finance International, Aflatoun, Childline India Foundation and Catalyst 2030. In this candid conversation we learn about her journey and discuss:

Solving for root cause problems

Creating impactful outcomes through co-creation and collaboration

Building collective ownership and trust

Letting go of ego and planning for organizational transition

Managing the relational and management aspects of scaling an organization and a movement

The art of listening

How to stay optimistic The journey of Catalyst 2030 in creating a social innovation sector

Advocacy and changing funder mindsets

Increasing representation from the Global South



Resources:

Join Catalyzing Change Week May 6-10, 2024: http://catalyst2030.info/RegisterCCW

Catalyst 2030: https://catalyst2030.net/

Jeroo Billimoria on Wikipedia: https://en.wikipedia.org/wiki/Jeroo_Billimoria

Sign up to our newsletter⁠, and stay informed of Dimagi’s work

We are on social media - follow us for the latest from Dimagi: ⁠LinkedIn⁠, ⁠Twitter⁠, ⁠Facebook⁠⁠⁠, ⁠Youtube⁠⁠⁠⁠

If you enjoy this show, please leave us a 5-Star Review and share your favorite episodes with friends. 

Hosts: ⁠Jonathan Jackson⁠ and ⁠Amie Vaccaro

Glasswing International is a NGO with a remarkable journey, having impacted more than 2.2 million lives through their education and health initiatives throughout Latin America and New York City. Co-founder and President Celina de Sola shares her insights on the organization's evolution and growth to 600 employees, and their community-driven approach that led to the organization's non-clinical model for mental health care. The podcast explores scalability, sustainability, and the role of technology and data in highlighting growth as well as the gaps, to enable organizations to achieve greater impact.

In this insightful podcast episode, we feature guests Andrea Fletcher, Chief Digital Strategy Officer, and Remy DeCausemaker, Open Source Lead at the Digital Service at Centers for Medicare and Medicaid Services (CMS), discussing the critical role of digital technology in shaping healthcare strategies within the U.S. government. The discussion delves into the intersections of technology, healthcare, and government strategies, emphasizing the significance of open source collaboration, addressing challenges, and preparing for the future of healthcare systems. Hear fresh perspectives on AI, privacy-enhancing technologies, and the importance of AI transparency in policies.